NCT06846775View on ClinicalTrials.gov

The Clinical Utility of DNA Methylation Testing in Patient-collected Urine and Vaginal Samples to Detect Endometrial Cancer: a Case-control Study

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

April 15, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2027

Conditions
Endometrial Cancer
Interventions
DIAGNOSTIC_TEST

DNA-methylation testing in patient-collected urine and vaginal samples

DNA-methylation testing of methylation markers CDO1, GHSR and ZIC1 for patient-collected vaginal samples and GHSR, CDH13 and SST for patient-collected urine samples.

Trial Locations (3)

5000

RECRUITING

Department of Obstetrics and Gynaecology, Odense University Hospital, Odense

8200

RECRUITING

Department of Obstetrics and Gynaecology, Aarhus University Hospital, Aarhus N

8930

NOT_YET_RECRUITING

Department of Orthopaedics, Randers Regional Hospital, Randers

All Listed Sponsors
collaborator

Central Denmark Region

OTHER

collaborator

University of Southern Denmark

OTHER

collaborator

Region of Southern Denmark

OTHER

collaborator

Amsterdam UMC

OTHER

lead

University of Aarhus

OTHER